← Eichor
Study identifier: NCT05709769 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Radiomics-based Malnutrition for Cervical Cancer.

Condition: Cervical Cancer · Malnutrition  ·  Sponsor: Zhejiang Provincial People's Hospital

PhaseN/A
Planned participants150
Who can joinFemale, 18 Years to 80 Years
Healthy volunteersNo

About this study

Loss of skeletal muscle, is one of the most prevalent symptoms of malnutrition, and has been frequently reported as a negative factor in cancer patients at any disease stage. In this study, we are planning to firstly analyze the radiomics features of psoas extracted at the level of the third lumbar vertebra (L3) and then, develop a CT-based radiomics nomogram prediction model for predicting malnutrition based on their Patient-Generated Subjective Global Assessment (PG-SGA) scores in patients with International Federation of Gynecology and Obstetrics (FIGO, 2014 version) stage IB1-IIA2 cervical cancer (CC) who received postoperative radiotherapy/chemoradiotherapy (RT/CRT).

This description comes directly from the study's public registry record.

Talk to the study team

Hong'en Xu, M.D.  ·  +86-571-85893638  ·  xuhongenzpph@sina.com

Huafeng Shou, M.D.  ·  +86-571-85893385  ·  hfshou@126.com

Always discuss trial participation with your own doctor first.

Locations (1)

Zhejiang Provincial People's HospitalHangzhou, Zhejiang, ChinaRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT05709769